News Release April 22, 2004 ConsumerLab.com shares insights from 2 years of testing supplements for athletic banned substances Athletes and manufacturers urged to learn how to avoid problems WHITE PLAINS, NY April 22, 2004 Two years after initiating the first program to test dietary supplements for substances banned from athletic competition, ConsumerLab.com today released a short advisory summarizing problems uncovered to-date from its testing
The threshold data paints a clearer picture
In a dose-ranging study in ESRD patients undergoing hemodialysis, patients received 10, 20, or 40 mg/kg Levocarnitine 3 times per week following dialysis (N~30 for each dose group)
Pancreatitis, gallbladder problems, and thyroid concerns have been documented in rare cases, which is why baseline health screening matters before starting therapy
In chronic wounds, a 2021 RCT (n=72 diabetic ulcers) reported 85% closure rate with GHK-Cu dressings at 12 weeks versus 55% control (OR 4.2